Myelodysplastic syndromes complicated by atypical Sweet syndrome: a brief research report
-
By
-
Bianhong Wang
-
Kun Qian
-
Hao Liu
-
Yuehua Huang
-
Yanying Wang
-
Lihong Li
-
Fan Yu
-
May 28, 2026
-
Clinical Report: Atypical Sweet Syndrome in Patients with Myelodysplastic Syndromes
Overview
{'add': 'Include patient demographics and MDS characteristics.'}
Background
{'expand': 'Discuss the clinical significance of atypical Sweet syndrome in MDS.'}
Data Highlights
{'add': 'Include specific MDS subtypes and treatment details.'}
Key Findings
{'clarify': 'Explain the connection between fever and skin lesions.'}
Clinical Implications
{'add': 'Suggest monitoring strategies for clinicians.'}
Conclusion
{'reiterate': 'Emphasize early diagnosis and treatment impact.'}
Related Resources & Content
- Blood Cancer Journal, 2016 -- Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment
- Blood Cancer Journal, 2022 -- Approaches to the Care of Patients with Lower-Risk Myelodysplastic Syndromes
- Blood Cancer Journal, 2014 -- Limited clinical efficacy of azacitidine in transfusion-dependent, growth factor-resistant, low- and Int-1-risk MDS: Results from the nordic NMDSG08A phase II trial
- Sweet syndrome: an update on clinical aspects, pathophysiology, and treatment - PubMed
- Clinical features, treatment, and outcome of granulocyte colony stimulating factor-induced sweet syndrome - PubMed
- Blood Cancer Journal — Myelodysplastic Syndrome in Children Linked to GATA2 Deficiency: A Focused Analysis
- Acute Febrile Neutrophilic Dermatosis - StatPearls - NCBI Bookshelf
- Sweet syndrome: an update on clinical aspects, pathophysiology, and treatment - PubMed
- Clinical features, treatment, and outcome of granulocyte colony stimulating factor-induced sweet syndrome - PubMed
